Peginterferon Lambda-1a (Lambda) is less likely to induce clinically significant neuropsychiatric symptoms during the treatment of chronic hepatitis C virus (HCV) infection, compared to peginterferon alfa-2a (Alfa)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Muir, AJ; Srinivasan, S; Sapra, S; Dimitrova, D; Hillson, JL; Lopez-Talavera, JC

Published Date

  • October 1, 2012

Published In

Volume / Issue

  • 56 /

Start / End Page

  • 578A - 579A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Conference Location

  • Boston, MA

Conference Start Date

  • November 9, 2012

Conference End Date

  • November 13, 2012